Form 4: Arteris Director Raman Chitkara Sells 5,000 Shares

Arteris, Inc. Director Raman Chitkara sold 5,000 shares of common stock on May 5, 2026, via a pre-arranged 10b5-1 trading plan.

Summary

• Director Raman Chitkara sold 5,000 shares of Arteris, Inc. (AIP) common stock.
• The shares were sold at a weighted average price of $30.0536 per share.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on March 7, 2025.
• Following the sale, the director retains beneficial ownership of 142,867 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned 10b5-1 arrangement, which is standard corporate governance practice.

Positives

• The sale was conducted through a pre-established 10b5-1 plan, which is a standard mechanism for insiders to sell shares without triggering concerns regarding non-public information.

Negatives

• The transaction represents a reduction in the director's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on current valuation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is common practice among technology executives and directors and generally does not reflect a change in the company's fundamental outlook.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for corporate insiders to manage liquidity while maintaining regulatory compliance.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and represents a small portion of the director's total holdings.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Arteris, AIP, Insider Trading, Form 4, Director Sale, Semiconductor